Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Alternative End-joining
20%
Biochemical Characterization
20%
Cytogenetic Analysis
20%
Cytogenetic Damage
20%
DNA Double-strand Breaks
20%
Double-strand Break Repair
40%
Error-free
20%
Error-prone
20%
Full Potential
20%
Further Development
20%
G2 Phase
20%
Genetic Characterization
20%
Genetic Modification
100%
Genome Sequence Analysis
20%
Genomic Advances
20%
Genomic Scars
20%
Homologous Recombination
40%
Human Fibroblast Cell Line
20%
Human Fibroblast Cells
100%
Human Telomerase Reverse Transcriptase (hTERT)
20%
Illumina Sequencing
20%
Ionizing Radiation Effects
20%
Large Deletion
20%
Left behind
20%
Mathematical Model
20%
Molecular Cytogenetics
20%
Multicolor Fluorescence in Situ Hybridization (mFISH)
20%
Next-generation Sequencing
100%
Next-generation Sequencing Technology
20%
Non-homologous End Joining
40%
PCR Analysis
20%
Pre-irradiation
20%
Radiation Exposure
20%
Radiation Therapy
20%
Radiobiological Effects
20%
Repair Pathway
20%
Sequence Analysis
20%
Single-strand Annealing
20%
Skin Fibroblasts
100%
Surviving Cells
20%
Survivors
100%
Medicine and Dentistry
Cell Cycle
33%
Cell Cycle Checkpoint
33%
Chromosome Analysis
33%
Double-Strand DNA Break
33%
Fibroblast
100%
Fibroblast Cell Line
33%
G2 Phase
33%
Homologous Recombination
66%
Illumina Dye Sequencing
33%
Ionizing Radiation
33%
Next Generation Sequencing
100%
Non-Homologous End Joining
100%
Radiation Exposure
66%
Radiation Therapy
33%
Radiation Treatment
33%
Immunology and Microbiology
Cell Cycle
33%
Cell Cycle Checkpoint
33%
Cell Cycle G2 Phase
33%
DNA End Joining Repair
100%
Double-Strand DNA Break
33%
Fibroblast
100%
Fibroblast Cell Line
33%
Homologous Recombination
66%
Illumina Dye Sequencing
33%
Next Generation Sequencing
100%
Normal Human
100%
Biochemistry, Genetics and Molecular Biology
Cell Cycle
16%
Cell Cycle Checkpoint
16%
Chromosome Analysis
16%
Cytogenetics
33%
Double-Strand DNA Break
16%
Fibroblast
100%
G2 Phase
16%
Genetics
16%
Genomics
100%
Homologous Recombination
33%
Illumina Dye Sequencing
16%
Next Generation Sequencing
100%
Non-Homologous End Joining
50%
Normal Human
100%